Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters

• Pubblicazione: [Washington, D.C.] : , : United States Government Accountability Office, , 2013
• Edizione: Revised.
• Descrizione fisica: 1 online resource (iii, 40 pages) : illustrations
• Soggetto topico: Medicaid - Claims administration; Prescription pricing - United States
• Note generali: Title from title screen (viewed Feb. 13, 2014).; "December 2013."; "This report was revised on February 6, 2014 to correct the omission of reprinting written comments from the Department of Health and Human Services (HHS) on a draft report. A copy of the HHS's written comments was inserted in appendix V."; "GAO-14-68."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Medicaid prescription drugs
• Titolo autorizzato: Medicaid prescription drugs
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910705120103321
• Lo trovi qui: Univ. Federico II